RMN is Reader Supported
Our Goal for APR 6 - MAY 5:
$1,420
Click Widget or Click Here to contribute.
Checks & Money Orders:
Raye Allan Smith
P.O. Box 95
Ashtabula, OH 44005
Users Online: 65
Who Founded
RMNews?
Dewitt Jones' Video
"Celebrate What's Right With The World"
"When the Starships Fly!"
Listen at YouTube
The
Theme for The Obergon Chronicles
Listen at YouTube
The Obergon Chronicles ebook
RUMOR MILL NEWS RADIO
CGI ROOM Common Ground Independent Media
WHAT ARE THE FACTIONS?
THE AMAZING RAYELAN ALLAN
BIORHYTHMS
LOTTO PICKS
OTHER WAYS TO DONATE
RUMOR MILL NEWS AGENTS WHO'VE BEEN INTERVIEWED ON RUMOR MILL NEWS
RADIO ______________
NOVEMBER 2008
Kevin Courtois - Kcbjedi
______________
Dr Robin Falkov
______________
Melinda Pillsbury Hr1
Melinda Pillsbury Hr2
______________
Daneen Peterson
______________
Daneen Peterson
______________
Disclosure Hr1
Disclosure Hr2
______________
Scribe
______________
in_PHI_nitti
______________
Jasmine Hr1
Jasmine Hr2
______________
Tom Chittum Hr1
Tom Chittum Hr2
______________
Kevin Courtois
______________
Dr Syberlux
______________
Gary Larrabee Hr1
Gary Larrabee Hr2
______________
Kevin Courtois
______________
Pravdaseeker Hr1
Pravdaseeker Hr2
______________
DECEMBER 2008
Tom Chittum
______________
Crystal River
______________
Stewart Swerdlow Hr1
Stewart Swerdlow Hr2
______________
Janet Swerdlow Hr1
Janet Swerdlow Hr2
______________
Dr. Robin Falkov Hr1
Dr. Robin Falkov Hr2
Dr. Robin Falkov Hr3
JANUARY 2009
______________
Patriotlad
______________
Patriotlad
______________
Crystal River
______________
Patriotlad
______________
Dr. Robin Falcov
______________
Patriotlad
FEBRUARY 2009
|
Find UFOs, The Apocalypse, New World Order, Political Analysis,
Alternative Health, Armageddon, Conspiracies, Prophecies,
Spirituality, Home Schooling, Home Mortgages and more, in:
The Rumor Mill News Reading Room
Experimental Antibiotic Kills Deadly Superbug
Posted By: RumorMail Date: Sunday, 7-Jan-2024 10:21:18
www.rumormill.news/234747
By Beth Mole - 1/5/2024
Snip
A new experimental antibiotic can handily knock off one of the world's most notoriously drug-resistant and deadly bacteria —in lab dishes and mice, at least. It does so with a never-before-seen method, cracking open an entirely new class of drugs that could yield more desperately needed new therapies for fighting drug-resistant infections.
The findings appeared this week in a pair of papers published in Nature, which lay out the extensive drug development work conducted by researchers at Harvard University and the Swiss-based pharmaceutical company Roche.
In an accompanying commentary, chemists Morgan Gugger and Paul Hergenrother of the University of Illinois at Urbana-Champaign discussed the findings with optimism, noting that it has been more than 50 years since the Food and Drug Administration has approved a new class of antibiotics against the category of bacteria the drug targets: Gram-negative bacteria. This category—which includes gut pathogens such as E. coli, Salmonella, Shigella, and the bacteria that cause chlamydia, the bubonic plague, gonorrhea, whooping cough, cholera, and typhoid, to name a few—is extraordinarily challenging to kill because it's defined by having a complex membrane structure that blocks most drugs, and it's good at accumulating other drug-resistance strategies
Weighty finding
In this case, the new drug—dubbed zosurabalpin—fights off the Gram-negative bacterium carbapenem-resistant Acinetobacter baumannii, aka CRAB. Though it may sound obscure, it's an opportunistic, invasive bacteria that often strikes hospitalized and critically ill patients, causing deadly infections worldwide. It is extensively drug-resistant, with ongoing emergence of pan-resistant strains around the world—in other words, strains that are resistant to every current antibiotic available. Mortality rates of invasive CRAB infections range from 40 to 60 percent. In 2017, the World Health Organization listed it as a priority 1: critical pathogen, for which new antibiotics are needed most urgently.
Zosurabalpin may just end up being that urgently needed drug, as Gugger and Hergenrother write in their commentary: "Given that zosurabalpin is already being tested in clinical trials, the future looks promising, with the possibility of a new antibiotic class being finally on the horizon for invasive CRAB infections."
An international team of researchers, led by Michael Lobritz and Kenneth Bradley at Roche, first identified a precursor of zosurabalpin through an unusual screen. Most new antibiotics are small molecules—those that have molecular weights of less than 600 daltons. But in this case, researchers searched through a collection of 45,000 bigger, heavier compounds, called tethered macrocyclic peptides (MCPs), which have weights around 800 daltons. The molecules were screened against a collection of Gram-negative strains, including an A. baumannii strain. A group of compounds knocked back the bacteria, and the researchers selected the top one—with the handy handle of RO7036668. The molecule was then optimized and fine-tuned, including charge balancing, to make it more effective, soluble, and safe. This resulted in zosurabalpin.
|
Read More
If you enjoyed this article,
Please consider a monthly subscription to Rumor Mill News!!
RMN is an RA production.
Articles In This Thread
- Experimental Antibiotic Kills Deadly Superbug
RumorMail -- Sunday, 7-Jan-2024 10:21:18
|
The only pay your RMN moderators receive comes from ads.
If you're using an ad blocker, please consider putting RMN in your ad blocker's whitelist.
Serving Truth and Freedom
Worldwide since 1996
Politically Incorrect News
Stranger than Fiction
Usually True!
Click Widget or Click Here to contribute.
^
AGENTS WEBPAGES
Provided free to RMN Agents
^
AGENTS WEBPAGES
Provided free to RMN Agents
|